Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charaf Benarafa

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Nature Microbiology|July 12, 2024
A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modificationsJacob Schön, G Tuba Barut, Bettina Salome Trüeb, et al.
Nature|December 22, 2021
Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not BetaLorenz Ulrich, Nico Joel Halwe, Adriano Taddeo, et al.
Nature Communications|October 7, 2022
The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotypeG Tuba Barut, Nico Joel Halwe, Adriano Taddeo, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Nature Microbiology|July 12, 2024
A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modificationsJacob Schön, G Tuba Barut, Bettina Salome Trüeb, et al.
Nature|December 22, 2021
Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not BetaLorenz Ulrich, Nico Joel Halwe, Adriano Taddeo, et al.
Nature Communications|October 7, 2022
The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotypeG Tuba Barut, Nico Joel Halwe, Adriano Taddeo, et al.
Pageof 7